Biomind BottleBiomind Bottle

BPC-157 / TB-500

SALE$92.00$69.00

Size:

Quantity:1

Bulk Options:

Select quantity · 10mg / Vial

FDA Disclaimer: The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All products are for laboratory developmental research USE ONLY.
VisaMasterCardZelleVenmoBitcoinEthereumUSDT+5 others

BPC-157 + TB500 (Thymosin Beta-4 Fragment)

The BPC-157 + TB500 composite is a high-purity, research-grade peptide formulation engineered for advanced investigation into multimodal tissue repair and cellular signaling mechanisms. This blend unites three structurally distinct yet functionally complementary peptides each extensively characterized in preclinical systems for their influence on inflammation dynamics, angiogenesis, cytoprotection, oxidative balance, and gene-level regulation of regeneration pathways.

Molecular Composition and Mechanistic Diversity

  • BPC-157 (Body Protection Compound 157): A synthetic 15-amino acid peptide derivative of gastric protein sequences, known for its exceptional stability across pH gradients and enzymatic conditions. Studies demonstrate rapid systemic uptake and targeted activity at endothelial and fibroblastic levels, implicating it in nitric oxide modulation, collagen synthesis, and vascular repair.

  • TB500 (Thymosin Beta-4 Fragment): A bioactive sequence fragment derived from thymosin beta-4, a ubiquitous actin-binding peptide. It regulates cytoskeletal reassembly, cell migration velocity, and intracellular transport processes. In controlled studies, TB500 promotes restoration of tissue integrity post-injury through enhanced cell motility and structural protein expression.

Integrated Research Applications

  • The dual peptide blend is formulated to enable multi-pathway experimental modeling, where the intersection of nitric oxide signaling, cytoskeletal regulation, ECM turnover, and oxidative stress management can be simultaneously assessed. Experimental domains include:

  • In vitro cell line assays for endothelial activation, fibroblast migration, and gene transcription profiling

  • Ex vivo tissue matrix systems assessing ECM deposition and angiogenic factors

  • In vivo preclinical models exploring coordinated inflammatory suppression and accelerated wound closure rates

By merging these peptides into a single formulation, researchers can evaluate both synergistic and divergent effects within unified experimental protocols eliminating the need for separate dosing strategies.

Analytical Validation and Quality Assurance

Identity and composition of each peptide component are verified through high-performance liquid chromatography (HPLC) and mass spectrometry (MS) profiling, ensuring reproducibility, purity, and batch consistency for laboratory use.

Storage and Stability Guidelines

Proper handling is essential to preserve peptide integrity:

  • Short-term storage: Refrigeration at approximately 4 °C (39 °F) is suitable for use within days to months.

  • Room temperature (lyophilized): Stable for several weeks when sealed and protected from light.

  • Long-term storage: Maintain at −80 °C (−112 °F) for preservation across extended research timelines (months to years).

    This blend’s stability, molecular precision, and complementary biochemical activity make it a uniquely powerful tool for research targeting integrated tissue healing, immune modulation, and regenerative signaling networks.

Frequently Asked Questions

GHK-Cu Influences gene expression involved in tissue remodeling and extracellular matrix regulation. It may support processes like collagen synthesis and skin or connective tissue repair in experimental models. BPC-157 Activates angiogenesis-related signaling (notably VEGFR2) and cell survival pathways, linked to vascular support and modulation of inflammatory responses in preclinical studies. TB-500 (Thymosin Beta-4 fragment) regulates actin dynamics, influencing cell migration and cytoskeletal organization that plays a role in tissue structure formation and cellular movement within regenerative models.
Researchers combine these peptides to investigate how different but complementary cellular mechanisms interact in regenerative biology. GHK-Cu contributes to extracellular matrix and collagen regulation, BPC-157 supports angiogenesis and vascular regeneration, and TB-500 promotes cytoskeletal reorganization and cellular motility. Together, they provide an integrated model for studying tissue repair, regeneration, and coordinated cellular signaling.
In laboratory and preclinical research, the combined use of GHK-Cu, BPC-157, and TB-500 has been associated with enhanced tissue repair and remodeling phases, modulation of inflammation and oxidative stress responses, increased collagen deposition and extracellular matrix stability and the promotion of angiogenesis and improved vascularization in tissue models. These outcomes suggest that multi-peptide combinations may help explore complex regenerative pathways at different stages of cellular recovery.

Test Results 10MG

Qualitative and Quantitative chemical analysis for BPC-157/TB-500 10MG by Ultra High Performance Liquid Chromatography with Mass Spectrometry

Similar Products

NextGenPeps

Reliable and innovative research with our top-grade research materials and novel research compounds tailored to lead the competitive research industry. Choose research quality. Choose NextGenPeps.

Get 10% Off Your First Order

Sign up now and receive a 10% discount code valid on your next purchase!

NextGenPeps LLC | Copyright 2025 NextGenPeps

The statements made within this website have not been evaluated by the US Food and Drug Administration. The statements and the products of this company are not intended to diagnose, treat, cure or prevent any disease. All Peptide research products on this site are for research and development use only, and not intended for human use.

NextGenPeps is a chemical supplier. NextGenPeps is not a compounding pharmacy or chemical compounding facility as defined under 503A of the Federal Food, Drug, and Cosmetic act. NextGenPeps is not an outsourcing facility as defined under 503B of the Federal Food, Drug, and Cosmetic Act.

GET 10% OFF